Related Experiment Video
Updated: Aug 17, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
Glycoconjugate vaccines. What next?
Insights
Haemophilus influenzae type b conjugate vaccines protect infants from invasive diseases. Further research into glycoconjugates is needed for optimal vaccine development, aligning with the Children's Vaccine Initiative.
Area of Science:
- Immunology
- Vaccinology
- Microbiology
Background:
- Invasive diseases caused by encapsulated organisms pose a significant threat to infants.
- The success of Haemophilus influenzae type b conjugate vaccines demonstrates the principle of protecting infants through vaccination.
Purpose of the Study:
- To outline the chemical and immunological specifications required for optimal glycoconjugate vaccines.
- To support the goals of the Children's Vaccine Initiative through vaccine development.
Main Methods:
- Review of existing data on conjugate vaccines.
- Analysis of chemical and immunological properties of glycoconjugates.
Main Results:
- Established the protective principle of conjugate vaccines against encapsulated organisms.
- Highlighted the need for defined specifications for glycoconjugate vaccine development.
Conclusions:
- Infant protection against invasive encapsulated bacterial diseases is achievable with conjugate vaccines.
- Clear chemical and immunological specifications are crucial for advancing glycoconjugate vaccine technology for initiatives like the Children's Vaccine Initiative.
Abstract:
The principle that infants can be protected from invasive diseases caused by encapsulated organisms has been proved with the introduction of Haemophilus influenzae type b conjugate vaccines. The use of glycoconjugates to implement some of the goals of the Children's Vaccine Initiative requires a clear delineation of the chemical and immunological specifications for optimal vaccines.
More Related Videos
Related Concept Videos
Vaccinations
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Protein Glycosylation
Glycosylation occurs in...
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Glycocalyx and its Functions
Components of...
Vaccine Production

